Federal investigators have determined that the contaminant found in the active pharmaceutical ingredient (API) in the heparin that has been associated with adverse reactions and deaths in the United States is a chemically altered form of chondroitin sulfate. Investigation of how the contaminant came to be there and whether it is actually the cause of reported adverse reactions is ongoing, according to a government spokesperson.